TY  - GEN

T1  - Cost consequence analysis of using the Elecsys Anti-Müllerian Hormone Plus immunoassay as part of polycystic ovary syndrome assessment in the United Kingdom

UR  - https://eprints.whiterose.ac.uk/id/eprint/219889

PY  - 2024/11/18

AU  - Garay U

AU  - Olziersky AM

AU  - Laven J

AU  - Mawson R

AU  - Piltonen T

AU  - Franks S

AU  - Sillman J

ED  - 

Y2  - 2025/11/05

ER  -